慢阻肺是我国常见的慢性气道疾病之一，其患病率及死亡率均位于前列。今年 11 月 15 日是第 22 个世界慢阻肺日，主题为「肺系生命，刻不容缓」。为提高临床医生对慢阻肺的诊治及管理水平，丁香园联合华西医院呼吸与危重症医学科展开系列活动，我们特邀陈 ...

为解决肺功能轨迹研究数据碎片化问题，研究人员通过整合8项欧洲和澳大利亚队列数据（n=30?438），首次采用加速队列设计 ...

FEV1 helps measure the progression of lung conditions such as chronic obstructive pulmonary disease (COPD) or asthma. FEV stands for forced expiratory volume, which is the air you exhale in one second ...

People who use wood burning stoves at home experienced faster declines in FEV1 compared with people who did not, according to ...

The phase 3 EXHALE-4 study demonstrated that dexpramipexole, an oral small molecule therapy, significantly improved ...

本研究针对传统支气管激发试验中FEV1绝对值20%下降（PD20）方法的局限性，创新性提出采用15%预测值下降（PD15%）标准。通过 ...

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by shortness of breath and a chronic cough. Although there’s no cure for this progressive lung disease, it can be ...

Research shows that forced expiratory volume in 1 second (FEV1) % predicted is ineffective for predicting mortality in elderly asthma patients. But the results also suggest that an alternative way of ...

Spirometry is a standard test doctors use to determine how well your lungs function. A score that measures airflow into and out of your lungs can help diagnose COPD and determine the best treatments.